Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Revenus
19
19
19
24
35
44
Croissance des revenus (H/H)
0%
0%
-21%
-31%
-20%
7%
Coût des ventes
7
7
7
9
13
14
Bénéfice brut
11
11
11
14
22
29
Vente, Général et Administration
11
11
13
17
34
44
Recherche et développement
0
0
--
--
--
--
Frais d'exploitation
14
14
15
24
39
49
Autres revenus (charges) non opérationnels
--
--
--
--
0
0
Bénéfice avant impôts
-2
-2
-3
-22
-70
-24
Charge d'impôt sur le revenu
--
--
--
--
0
0
Bénéfice net
-4
-4
-7
-26
-74
-25
Croissance du bénéfice net
-43%
-43%
-73%
-65%
196%
-308%
Actions en circulation (diluées)
8.96
4.02
0.53
0.25
0.16
0.15
Variation des actions (H-H)
992%
646%
112.99%
52%
9%
22%
EPS (dilué)
-0.48
-1.08
-14.29
-106.57
-446.43
-170.06
Croissance du EPS
-95%
-92%
-87%
-76%
163%
-274%
Flux de trésorerie libre
-1
-1
0
-4
-15
-14
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
57.89%
57.89%
57.89%
58.33%
62.85%
65.9%
Marge opérationnelle
-10.52%
-10.52%
-15.78%
-37.5%
-48.57%
-43.18%
Marge bénéficiaire
-21.05%
-21.05%
-36.84%
-108.33%
-211.42%
-56.81%
Marge du flux de trésorerie libre
-5.26%
-5.26%
0%
-16.66%
-42.85%
-31.81%
EBITDA
-1
-1
-2
-8
-16
-18
Marge EBITDA
-5.26%
-5.26%
-10.52%
-33.33%
-45.71%
-40.9%
D&A pour le résultat opérationnel
1
1
1
1
1
1
EBIT
-2
-2
-3
-9
-17
-19
Marge EBIT
-10.52%
-10.52%
-15.78%
-37.5%
-48.57%
-43.18%
Taux d'imposition effectif
--
--
--
--
0%
0%
Follow-Up Questions
cbdMD Inc의 주요 재무제표는 무엇인가요?
YCBD의 주요 재무 비율은 무엇인가요?
cbdMD Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
cbdMD Inc은 수익성이 있나요?
cbdMD Inc에 부채가 있나요?
cbdMD Inc의 발행 주식은 몇 주인가요?
Statistiques clés
Clôture préc.
$0.795
Prix d'ouverture
$0.7887
Plage de la journée
$0.7502 - $0.7928
Plage de 52 semaines
$0.47 - $5.96
Volume
303.4K
Volume moyen
11.0M
BPA (TTM)
-0.82
Rendement en dividend
0.00%
Capitalisation boursière
$6.7M
Qu’est-ce que YCBD ?
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.